Search
for
Sort by
Research 331–360 of 1000+
- Effects of Mitoquinone on Doxorubicin-Induced Cytotoxicity in H9c2 Cardiac Myoblasts and 22Rv1 Prostate Cancer Cells
- FERTILITY-SPARING MANAGEMENT OF ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA & ENDOMETRIAL CANCER: A COMPARISON OF THE LEVONORGESTREL-RELEASING INTRAUTERINE DEVICE VS SYSTEMIC THERAPY
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways
- Skin toxicity of anti‐cancer therapy
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Androgen receptor: A promising therapeutic target in breast cancer
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Review of Drug Repositioning in Cancer Therapeutics
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- Management of Advanced Prostate Cancer Undergoing Major Shift
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- A CONCEPTUAL REVIEW OF AYURVEDIC HERBAL AND MINERAL FORMULATIONS IN ARBUDA WITH SPECIAL REFERENCE TO CANCER
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Dutasteride for the treatment of benign prostatic hyperplasia
- Niacin deficiency increases the sensitivity of rats to the short and long term effects of ethylnitrosourea treatment.
- Use of spironolactone in treatment of hirsutism
- Hair loss in cancer chemotherapeutic patients.
- Equivalent chemotherapy efficacy against leukemia in mice treated with topical vasoconstrictors to prevent cancer therapy side effects
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Research advances of tissue-derived extracellular vesicles in cancers
- A NEW GENERATION OF MARKERS FOR CANCER DETECTION AND DRUG TRANSPORT
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)